Occudo Quantitative Strategies LP Alkermes Plc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $605,852 - $718,942
21,378 New
21,378 $669,000
Q3 2022

Nov 14, 2022
SELL
$22.0 - $31.87 $652,410 - $945,104
-29,655 Reduced 17.33%
141,467 $3.16 Million
Q2 2022

Aug 15, 2022
BUY
$26.4 - $30.54 $4.52 Million - $5.23 Million
171,122 New
171,122 $5.1 Million
Q1 2021

May 14, 2021
SELL
$18.21 - $23.2 $291,705 - $371,640
-16,019 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.39 - $22.1 $246,532 - $354,019
16,019 New
16,019 $320,000

Others Institutions Holding ALKS

# of Institutions
364
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.61B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email